Base Peptides

Australia's premium research peptide supplier. Independent university lab testing. Same-day dispatch from Sydney. Research use only.

[Karl Stefanovic @karlstefanovic]

Karl breaks his silence. Piers Morgan 6pm.

[Karl Stefanovic @karlstefanovic]

Free speech is important.
Thanks @elonmusk for this platform.

[Sandeep Palakodeti, MD MPH @DrDeepMD]

I’m pretty convinced, personally, on the power of Epitalon, so I made this guide below to share with you all

Have run several cycles myself and increasingly have patients reporting same outcomes

I’ve seen others state it’s “not a sleep peptide”. That’s…not really true…

Khavinson frames it as a geroprotector

But strongest mechanism is restoration of melatonin synthesis and normalization of cortisol, both of which are major causes of sleep disruption

From his 2001 monkey study: “Epitalon was proven to significantly stimulate melatonin synthesis in senescent monkeys in the evening, thereby normalising the circadian rhythm of cortisol secretion.”

Of course, many other impacts like decelerated cardiovascular aging, prevented age-associated impairment of physical endurance, and improved carbohydrate and lipid metabolism

But, in today’s day and age, anything that can give us a natural melatonin boost and chill out our cortisol, is going to solve most of our biggest problem: sleep

July FDA hearing to decide if approved for insomnia

Wild times ahead!

[Max Marchione @maxmarchione]

I microdose retatrutide for focus.

On reta, I barely think about food.

Food-related willpower is a tax on the rest of your life, and you don't realize how much cognitive bandwidth it consumes until it's gone.

[Secretary Kennedy @SecKennedy]

Today, we took long-overdue action to restore science, accountability, and the rule of law.

In September 2023, the Biden FDA pushed a number of peptides into Category 2 — “Bulk Drug Substances that Raise Significant Safety Risks” — driving a dangerous black market that puts Americans at risk.

Now, after nominators withdrew 12 peptides, the FDA will remove them from Category 2 and will bring them to PCAC at its next two meetings, beginning in July—where independent experts will rigorously evaluate each substance on its scientific merits using full clinical, pharmacological, and safety evidence.

• BPC-157
• Thymosin beta-4 fragment (LKKTETQ)
• Epitalon
• GHK-Cu (injectable)
• MOTS-c
• DSIP (Emideltide)
• Dihexa Acetate
• Ibutamoren Mesylate
• Melanotan II
• KPV
• Semax (heptapeptide)
• Cathelicidin LL-37

This action begins to restore regulated access and will immediately begin shifting demand away from the black market.

We will follow the science, enforce the law, and deliver the clarity patients, providers, and pharmacies deserve.

[Tim Medley @BioHackingTim]

https://t.co/0d5WeoSpzB

[Tim Medley @BioHackingTim]

The perceived notion of there being an inverse relationship between sleep and productivity was broken wide open by the introduction of nootropic

Akin to the ai revolution, those participating will far surpass the rest

[Tim Medley @BioHackingTim]

Last generations founders and industry titans leaned heavily on Adderall and other stimulants.

The next waves core stack will revolve around Semax and other nootropic peptides.

[Tim Medley @BioHackingTim]

https://t.co/Has0uBOQnh